Warburg Pincus Completes Financing of Silk Road Medical
07.18.17
This is only gets display when printing
Simpson Thacher represented Warburg Pincus in connection with a $47 million new financing for Silk Road Medical, Inc. The round included existing investors Warburg Pincus, The Vertical Group and CRG, as well as new investors Norwest Venture Partners and Janus Capital Management LLC. The funds will be used to support Silk Road’s rapid growth of its ENROUTE family of products for TransCarotid Artery Revascularization (TCAR) procedures.
Silk Road is a private company focused on the development and manufacturing of less-invasive medical devices intended to improve the treatment of carotid artery diseases through proprietary transcartoid therapies.
The Simpson Thacher team included Robert Langdon, Mark Myott (M&A); Colin Lloyd (Corporate); and Jeannine McSweeney (ECEB).